禁煙治療薬の世界市場:ニコチン置換療法(NRT)、電子たばこ

Technavioが発行した調査報告書(IRTNTR8278)
◆英語タイトル:Global Smoking Cessation Drugs Market 2016-2020
◆商品コード:IRTNTR8278
◆発行会社(リサーチ会社):Technavio
◆発行日:2016年4月27日
◆ページ数:74
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名利用)USD2,500 ⇒換算¥282,500見積依頼/購入/質問フォーム
Five User(~5名利用)USD3,000 ⇒換算¥339,000見積依頼/購入/質問フォーム
Enterprise License(全社内共有可)USD4,000 ⇒換算¥452,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はTechnavio社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。Technavio社の概要及び新刊レポートはこちらでご確認いただけます。

当調査レポートでは、禁煙治療薬の世界市場について調査・分析し、エグゼクティブサマリー、市場概観、市場概観、業界の構造分析、疫学分析、禁煙治療薬の世界市場規模及び予測、種類別分析、処方薬/OTC薬別分析、地域別分析/市場規模、市場の成長要因、市場の課題、製品パイプライン分析、市場動向、競争状況などの情報をお届けいたします。

・エグゼクティブサマリー
・市場概観
・業界の構造分析
・疫学分析
・禁煙治療薬の世界市場:市場規模及び予測
・禁煙治療薬の世界市場:種類別分析
・禁煙治療薬の世界市場:処方薬/OTC薬別分析
・禁煙治療薬の世界市場:地域別分析
・禁煙治療薬の世界市場:アジア市場規模
・禁煙治療薬の世界市場:アメリカ市場規模
・禁煙治療薬の世界市場:ヨーロッパ市場規模
・禁煙治療薬の世界市場:成長要因
・禁煙治療薬の世界市場:課題
・製品パイプライン分析
・市場動向
・競争状況
...

※上記の和訳は最新内容ではない場合があります。
【レポートの概要】

About Smoking Cessation Products
Smoking cessation products such as NRTs and e-cigarettes have proved useful in reducing the numbers of smokers worldwide. They can also be used to reduce smoking. A substantial number of smokers are now either quitting or trying to reduce smoking. This is because of increased awareness about the adverse effects of smoking; it is associated with a number of health hazards that can eventually lead to death. This is encouraging people to adopt smoking cessation products. Public awareness programs help create awareness about the hazards of smoking, and also the availability of products that help quit smoking.

Technavio’s analysts forecast the global smoking cessation products market to grow at a CAGR of 18.16% during the period 2016-2020.

[Covered in this report]
The report covers the present scenario and the growth prospects of the global smoking cessation products market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of prescription, generic, off-label, and over-the-counter (OTC) products used for smoking cessation.

The market is divided into the following segments based on geography:
• Americas
• APAC
• EMEA

Technavio’s report, Global Thoracic Surgery Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

[Key vendors]
• GlaxoSmithKline
• Imperial Tobacco
• NJOY
• Pfizer
• Reynolds American

[Other prominent vendors]
• 22nd Century Group
• Alkalon
• Altria Group
• Aradigm
• Arena Pharmaceuticals
• Ballantyne Brands
• British American Tobacco (BAT)
• CB Distributors
• Cytos Biotechnology
• Electronics Cigarettes International Group (Victory Electronic Cigarettes)
• Evotec
• Gamucci
• Japan Tobacco
• Johnson & Johnson
• LOGIC Technology
• NAL Pharmaceuticals
• Nicotek
• Novartis
• Revolymer
• RR Chemicals
• Selecta Biosciences
• Target
• The Harvard Drug Group
• Vapor
• VMR Products
• Walgreens
• Wal-Mart
• White Cloud

[Market driver]
• High awareness of risks associated with tobacco use
• For a full, detailed list, view our report

[Market challenge]
• Relapse after treatment
• For a full, detailed list, view our report

[Market trend]
• Ban on tobacco advertisements
• For a full, detailed list, view our report

[Key questions answered in this report]
• What will the market size be in 2020 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?

※You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.

【レポートの目次】

PART 01: Executive summary
• Highlights

PART 02: Scope of the report
• Market overview
• Top-vendor offerings

PART 03: Market research methodology
• Research methodology
• Economic indicators

PART 04: Introduction
• Key market highlights

PART 05: World cigarette statistics: Per capita consumption per year

PART 06: Epidemiology
• US

PART 07: Health implications of smoking
• Risk of tobacco smoke on non-smokers

PART 08: Regulations on tobacco use
• Impact of smoking bans on businesses
• Economic benefits to individuals

PART 09: Pipeline analysis
• NAL2762
• X-22
• APD356
• GSK598809
• SEL-068
• ARD-1600

PART 10: Market landscape
• Market overview
• Market size and forecast
• Five forces analysis

PART 11: Market segmentation by type
• Global smoking cessation drugs market
• Global NRTs market
• Global e-cigarette market

PART 12: Market segmentation by availability
• Prescription products
• OTC products

PART 13: Geographical segmentation
• Global smoking cessation products market by geography 2015-2020
• Smoking cessation products market in Americas
• Smoking cessation products market in EMEA
• Smoking cessation products market in APAC

PART 14: Market drivers
• Increase in number of smokers
• Increase in teenage smoking
• Significant number of public awareness programs
• High awareness of risks associated with tobacco use

PART 15: Impact of drivers

PART 16: Market challenges
• Side effects associated with drugs and therapies
• Relapse after treatment
• Weak R&D on drugs

PART 17: Impact of drivers and challenges

PART 18: Market trends
• Increase in use of e-cigarettes
• Increased innovation in smoking cessation products
• Ban on tobacco advertisements
• Increased pictorial warnings on cigarette packages

PART 19: Vendor landscape
• Competitive scenario
• GlaxoSmithKline
• Imperial Tobacco
• NJOY
• Pfizer
• Reynolds American
• Other prominent vendors

PART 20: Appendix
• List of abbreviations

PART 21: Explore Technavio

[List of Exhibits]

Exhibit 01: Product offerings
Exhibit 02: Common health effects caused by smoking
Exhibit 03: Smoking cessation products: Pipeline portfolio
Exhibit 04: Discontinued projects
Exhibit 05: Global smoking cessation products market 2015-2020 ($ billions)
Exhibit 06: Five forces analysis
Exhibit 07: Global smoking cessation products market by type
Exhibit 08: Global smoking cessation products market by type 2015
Exhibit 09: Global smoking cessation drugs market 2015-2020 ($ billions)
Exhibit 10: Global NRTs market 2015-2020 ($ billions)
Exhibit 11: Global NRTs market by product 2015
Exhibit 12: Global nicotine patch market 2015-2020 ($ billions)
Exhibit 13: Nicotine patch market by geographical region 2015
Exhibit 14: Global nicotine gum market 2015-2020 ($ billions)
Exhibit 15: Nicotine gum market by geographical region 2015
Exhibit 16: Global e-cigarette market 2015-2020 ($ billions)
Exhibit 17: Global e-cigarette market: Product life cycle analysis 2015
Exhibit 18: E-cigarette market by geographical region 2015
Exhibit 19: Global smoking cessation products market by availability
Exhibit 20: Global smoking cessation products market by geography 2015
Exhibit 21: Global smoking cessation products market by geography 2020
Exhibit 22: Global smoking cessation products market revenue by geography 2015-2020 ($ billions)
Exhibit 23: Smoking cessation products market in Americas 2015-2020 ($ billions)
Exhibit 24: Smoking cessation products market in EMEA 2015-2020 ($ billions)
Exhibit 25: Smoking cessation products market in APAC 2015-2020 ($ billions)
Exhibit 26: Impact of drivers
Exhibit 27: Impact of drivers and challenges
Exhibit 28: Implementation of picture warnings in various countries
Exhibit 29: GlaxoSmithKline: Business segmentation by revenue 2014
Exhibit 30: GlaxoSmithKline: Business segmentation by revenue 2013 and 2014 ($ billions)
Exhibit 31: GlaxoSmithKline: Geographical segmentation by revenue 2014
Exhibit 32: GlaxoSmithKline: Key takeaways
Exhibit 33: Imperial Tobacco: Business segmentation by revenue 2014
Exhibit 34: Imperial Tobacco: Business segmentation by revenue 2013 and 2014 ($ billions)
Exhibit 35: Imperial Tobacco: Key takeaways
Exhibit 36: NJOY: Product categories
Exhibit 37: NJOY: Key takeaways
Exhibit 38: Pfizer: Business segmentation by revenue 2014
Exhibit 39: Pfizer: Business segmentation by revenue 2013 and 2014 ($ billions)
Exhibit 40: Pfizer: Geographical segmentation by revenue 2014
Exhibit 41: Pfizer: YoY growth and revenue of Chantix or Champix ($ millions)
Exhibit 42: Pfizer: Key takeaways
Exhibit 43: Reynolds American: Business segmentation by revenue 2014
Exhibit 44: Reynolds American: Business segmentation by revenue 2013 and 2014 ($ billions)
Exhibit 45: Reynolds American: Key takeaways



【掲載企業】

GlaxoSmithKline, Imperial Tobacco, NJOY, Pfizer, Reynolds American, 22nd Century Group, Alkalon, Altria Group, Aradigm, Arena Pharmaceuticals, Ballantyne Brands, British American Tobacco (BAT), CB Distributors, Cytos Biotechnology, Electronics Cigarettes International Group (Victory Electronic Cigarettes), Evotec, Gamucci, Japan Tobacco, Johnson & Johnson, LOGIC Technology, NAL Pharmaceuticals, Nicotek, Novartis, Revolymer, RR Chemicals, Selecta Biosciences, Target, The Harvard Drug Group, Vapor, VMR Products, Walgreens, Wal-Mart, White Cloud.

【レポートのキーワード】

禁煙治療薬、ニコチン置換療法(NRT)、電子たばこ

【リサーチ方法】

一次資料による調査(業界専門家、ベンダー、代理店、顧客等を対象にしたデプスインタビュー調査など)及び二次資料による調査(Technavio独自のプラットフォーム、産業書籍、企業報告書、ニュース記事、アナリストレポート、貿易協会、政府機関発行データなど)

【免責事項】
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 禁煙治療薬の世界市場:ニコチン置換療法(NRT)、電子たばこ(Global Smoking Cessation Drugs Market 2016-2020)]についてメールでお問い合わせはこちらでお願いします。


◆H&Iグローバルリサーチのお客様(例)◆